Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cefepime versus ceftriaxone in elective orthopedic surgery at Bugando
PACTR201406000803420Not yet recruiting
- Sponsor
- Catholic University of Health and Allied Sciences
- Start
- Jun 2014
- Modality
- Small Molecules, Reversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label trial of cefepime and ceftriaxone in surgical site infection (SSI) (2 arms), sponsored by Catholic University of Health and Allied Sciences. Primary endpoint: Surgical site infection. Planned start Jun 2014; status: not yet recruiting.
02
Drugs
cefepimeceftriaxone
03
Conditions
surgical site infection (SSI)
Beyond the preview
Go deeper on PACTR201406000803420.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR201406000803420.